North America Wheelchair Accessible Vehicle Converters Market: Growing Usage of Mobility Assistive Devices to Augur Well for WAV Manufacturers

The North America wheelchair accessible vehicle (WAV) converters market is consolidated, with the top three players – BraunAbility, Vantage Mobility International, and Mobility Ventures LLC – accounting for over 65% in 2015. Transparency Market Research has observed that WAV manufacturers and vehicle converters are increasingly focusing on strengthening their distribution networks, developing a steady sales force, and conducting awareness programs in order to increase the adoption of WAVs over the forecast period.

Transportation companies are also looking to capitalize on the opportunities presented by this market through WAV taxi services. For instance, in July 2015, Uber Technologies, Inc. announced the launch of UberACCESS, which provides mobility vehicles for disabled customers. Wheelchair accessible vehicle taxi services are gaining traction in the U.S. and this is expected to give the WAV converters market a considerable boost in the coming years.

The value of the North America wheelchair accessible vehicle converters market was pegged at US$781.8 mn in 2015 and is expected to reach US$1.9 bn by 2024, registering a CAGR of 11.1% therein.

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16094

By Entry Modality, Ramps Present Most Lucrative Opportunities for Players

On the basis of size of vehicle, full-sized vehicles are expected to account for a 73.1% share in the wheelchair accessible vehicle converters market by 2024. Small-sized vehicles, on the other hand, form the most attractive segment. This segment is projected to expand at a strong CAGR of 11.4% from 2016 to 2024.

By entry modality, ramps form the leading segment of the wheelchair accessible vehicle converters market in North America and this segment is anticipated to exhibit high growth through the forecast period.

From a geographical standpoint, the U.S. market is estimated to account for an 88.3% revenue share by 2024, emerging as the clear leader in the North America wheelchair accessible vehicle converters market. The U.S. is also projected to be the most lucrative segment by 2024.                                                                                              

Introduction of Preemptive Accommodations by WAV Manufacturers a Key Marketing Strategy

One of the key factors driving the North America market for wheelchair accessible vehicle converters is the significant prevalence of people with disabilities. A recent study published by the Centers for Disease Control and Prevention (CDC) states that one out of every five adults in the U.S. has a disability. This translates to roughly 53 million adults currently living with some form of disability. Disabled World, an independent news portal, reveals that an estimated 6.8 million community-resident Americans use mobility assistive devices, of which, at least 1.7 million individuals are wheelchair or scooter riders. “With the number of people living from disabilities on the rise, the demand for wheelchair accessible vehicle converters is bound to grow,” the TMR analyst states.

Looking to increase the adoption rate of wheelchair accessible vehicles and offer more benefits to customers, WAV manufacturers are focusing on integrating advanced technologies with their products. The introduction of preemptive accommodations is one such example, wherein WAV manufacturing companies are partnering with parking authorities in major cities to notify WAV users regarding the availability of parking spaces. Developments such as these are sure to boost the wheelchair accessible vehicle converters market in North America.

On the flip side, the high cost of wheelchair accessible vehicles and low awareness among potential customers are expected to significantly hamper the adoption rate of mobility vehicles, thereby hurting the wheelchair accessible vehicle converters market in North America.

Browse Full Research Report on Wheelchair Accessible Vehicle Converters Market:
http://www.transparencymarketresearch.com/north-america-wheelchair-accessible-vehicle-converters-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Latex Medical Disposables Market : Opportunity Map and Trends 2024

Latex Medical Disposables Market: Snapshot

The global latex medical disposables market has witnessed significant growth over the last decade primarily owing to the urgent need for infection control. The demand for latex medical disposables is not just limited to super specialty hospitals but has, of late, expanded to rural hospitals and clinics.

The opportunity in the global latex medical disposables market is expected to amount to US$6.4 bn by 2024, rising from a value of US$4.1 bn in 2015 at a modest CAGR of 4.9% therein. The growth in this market can be attributed to an expanding medical tourism industry across developing countries, vigorous growth of the healthcare sector, rising focus of the government toward the medical devices market, and growing healthcare awareness among the population.

Download Complete Healthcare Analytical Brochure: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16109

Hospitals Emerge as Leading End User of Latex Medical Disposables

By product, latex gloves emerged as the leading segment of the latex medical disposables market, accounting for a 60.4% share in terms of revenue in 2015. Latex foley catheters and latex probe covers also show significant scope for growth and the trend is likely to continue through 2024.

The key end users latex medical disposables include hospitals (private and public), ambulatory surgical centers, clinics, and diagnostic centers. Hospitals formed the dominant segment in terms of revenue in 2015, attributed to a significantly high demand. The consumption of latex medical disposables is high in hospitals because of the increased number of procedures carried out and the growing preference of patients toward public and private hospitals. The hospital segment is expected to account for a 28.7% share in 2024, closely followed by diagnostic centers.

Developing Markets of Asia Pacific and Latin America Show Immense Promise

North America leads the global latex medical disposables market and factors such as the increasing geriatric population and the introduction of new material variants by global players for the betterment of healthcare professionals can be attributed to the region’s dominance in the global market. In addition, a rise in infection control awareness has played a vital role in increasing healthcare expenditure in the region. The U.S. accounts for a major share in the North America as well as worldwide latex medical disposables market.

Europe is also a prominent contributor to the global latex medical disposables market due to a well-established healthcare network in the region. The demand for latex disposables is increasing owing to the rising number of ambulatory surgical centers as well as their growing use in home-care settings. Despite the ongoing debate about latex allergies, the size of this market is likely to expand during the course of the forecast period.

The Asia Pacific latex medical disposables market is projected to expand at the fastest CAGR during the forecast period, with China as its lead contributor. Increasing population and consumption of latex products in the country is expected to provide lucrative opportunities for global players. Moreover, a rise in the demand for other latex products such as probe covers and foley catheters in Japan and India is likely to complement the growth of the latex medical disposables market in Asia Pacific.

Players in the latex medical disposables market have been focused on strengthening their presence in Latin America due to the rising number of private hospitals in Brazil, Mexico and other countries in the region.

Key players in the latex medical disposables market include B. Braun Melsungen, Medtronic plc. (Covidien), C.R. Bard, Ansell, Hartalega Holdings Bhd., Top Glove Corporation, Supermax Corporation Berhad, and Dynarex Corporation.

Browse Full Research Report on Latex Medical Disposables Market:
http://www.transparencymarketresearch.com/latex-medical-disposables-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Healthcare Mobility Solutions Market By End-user, 2015 to 2023

Focus on Reducing Healthcare Costs Drives Global Market

The constantly growing and evolving medical needs have been the driving force behind the evolution of healthcare mobility solutions. The aim of these solutions is to reduce the healthcare costs and to provide the patients an optimum solution in the least possible time. The simplicity of this objectivity has been successfully achieved by the development of healthcare mobility solutions’ products and services such as mobile devices, enterprise mobility platforms, and mobile applications. The growing demand for medical attention and increasing usage of smartphones and other personal digital assistants have made the deployment of this technology possible. It has bridged the gap between patients and caregivers by facilitating help through technology.

With this strong background, the global healthcare mobility solutions market touched a valuation of US$20.13 bn in 2014. Given the high-impact drivers, this market is expected to see opportunities worth US$148.66 bn by 2023, as the market is expected to progress at a CAGR of 25.50% from 2015 to 2023.

Download Complete Healthcare Analytical Brochure: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4773

Preference for Home Healthcare Services Keeps North America at the Forefront

North America held the leading share in the overall healthcare mobility solutions market, accounting for 53.0% of the total market revenue in 2014. The mHealth application is driving the flourishing healthcare mobility solutions market in North America as more and more patients are opting for home healthcare services.

Furthermore, the increasing efforts to save on healthcare costs is also expected to propel the mHealth applications market, which will, in turn, result in the growth of healthcare mobility solutions across North America. Government initiatives along with efforts taken by private establishments across the U.S. and Canada to adopt convenient and cost-effective solutions is also likely to propel this market.

Asia Pacific Shows Promise of Growth as Governments Encourage e-Health Solutions

Meanwhile, Asia Pacific is expected to surge at an unprecedented CAGR of 25.8% between 2015 and 2023. The growing government initiatives to increasing the adoption rate of e-Health solutions and mHealth across countries such as India, Japan, Australia, New Zealand, and China are expected to drive this regional market. The growing awareness about mobile health options, clinical mobility, and convenience of home monitoring are expected to augment the Asia Pacific healthcare mobility solutions market.

Amongst the various types of applications offered by healthcare mobility solutions such as enterprise solutions and mHealth applications, the latter is expected to exhibit the fastest growing CAGR of 25.2% between 2015 and 2023. The spiraling usage of smartphones, tablets, and PDAs is expected to propel this application segment in the near future. Supplementing this growth will the rise of the mobile devices segment due to their affordability, accessibility, and convenience. The improving features of mobile applications and the streamlining of information feed and its assessment will work in favor of both these segments to help the overall market prosper in the coming years.

The key players rendering the competitive landscape of the global healthcare mobility solutions market fragmented are Cerner Corporation, McKesson Corporation, SAP SE, Koninklijke Philips N.V., Oracle Corporation, Cisco Systems, Inc., and AT&T, Inc. The majority of the companies in this market are trying to explore the opportunities in the emerging economies of Brazil, Chile, and India to increase their geographical foothold. 

Browse Full Research Report on Healthcare Mobility Solutions Market:
http://www.transparencymarketresearch.com/healthcare-mobility-solutions-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Value Chain Analysis for Biotechnology Industry its value to US$414.5 Billion by 2017

The global biotechnology market features prominent players such as F. Hoffman-La Roche Ltd., Abbott Laboratories Inc., Gilead Sciences, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, AstraZeneca plc, GlaxoSmithKline plc, Amgen Inc., Novartis International AG, Sanofi, Genentech Inc., Celgene Corporation, Lonza Group Ltd., and Novo Nordisk A/S. 

According to Transparency Market Research (TMR), the global biotechnology market is expected to be valued at US$414.5 bn by the end of 2017. 

Download Complete Biotechnology Industry Analytical Brochure: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=498

Biopharmaceuticals to Remain Key Revenue Generator for Global Biotechnology Market

By application, the global biotechnology market is segmented into biopharmaceuticals, bioagriculture, bioindustrial services, and bioservices. Of these, biopharmaceuticals hold the leading share in the global biotechnology market and are likely to remain the leading contributor to the market in the coming years. Bioagriculture is also likely to become a leading revenue generator for the global biotechnology market in the coming years, primarily due to the rising demand for bioengineered seeds. 

By technology, the report segments the global biotechnology market into DNA sequencing, polymerase chain reaction, nanobiotechnology, cell-based assays, fermentation, chromatography, tissue engineering and regeneration, and fingerprinting and enzyme technology. Of these, nanobiotechnology is likely to exhibit rapid growth over the coming years due to its growing application in healthcare and other sectors. The application of nanotechnology in the healthcare sector is rising due to the diversity of its potential applications, and the nanobiotechnology sector could benefit from the research being conducted to explore other possible applications of nanotechnology solutions. 

Geographically, North America is the leading contributor to the global biotechnology market in the coming years, followed by Asia Pacific and Europe. Despite the rising demand for advanced biotechnology solutions from Asia Pacific, North America is set to retain the dominant regional segment of the global biotechnology market. 

Favorable Government Regulations Supporting Biotechnology R&D to Enable Steady Growth

The prime driver for the global biotechnology market is the rising scarcity of food across the world. This has driven consistent R&D into the application of biotechnology to enhance the output of food crops, which will help solve the mounting hunger crisis. The rising demand for biotechnologically enhanced seeds is likely to remain a key driver for the global biotechnology market, as populous countries such as China and India are the leading consumers of biotechnological enhancements that help boost the overall output of the agriculture sector. The bioagriculture segment of the global biotechnology market is expected to be valued at close to US$27.5 bn by 2018. 

The rising awareness about the notable benefits of biotechnology solutions and the diversity of fields in which they can be employed has led to sustained government support, which is expected to remain a key driver for the global biotechnology market in the coming years. Due to the highly sophisticated technology used in biotechnology research, a sustained influx of investment is required for long-term research. This has made government support crucial for the global biotechnology market. 

The rising use of biotechnology solutions in the healthcare sector is another key driver for the global biotechnology market. The utilization of biosimilars in a wide range of medical procedures has boosted the demand for biotechnology solutions, while the use of stem cell technology and nanotechnology have also been important for the global biotechnology market. 

The information in this preview comes from a Transparency Market Research report titled ‘Global Biotechnology Market by Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), by Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2010 - 2017.’

Browse Full Research Report on Global Biotechnology Market: 
http://www.transparencymarketresearch.com/biotechnology-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Home Healthcare Segment to Drive the Demand of the Global Medical Device Connectivity Market in the Forecast Period

The global medical device connectivity (MDC) market is highly consolidated. The top four players, namely Phillips Healthcare, GE Healthcare, Cerner Corp., and Capsule Tech. Inc., held around 80.0% of the market in 2012. The market is marked by cutthroat competition with most players channelizing their efforts towards the development of innovative open source solutions to gain an edge over others. Solution providers are partnering with suppliers comprising medical device manufacturers and network providers in order to offer innovative and customized connectivity solutions to users.

Capsule Tech Inc., which held over 40.0% of the market in 2012, has expanded its business globally through agreements with over 60 medical device manufacturers to cater to the needs of hospitals and healthcare facilities. Among other players, Phillips and GE have consistently focused on research and development to come up with new products and processes to retain and improve their market share. Cerner Corp.’s business strategies, on the other hand, have revolved around acquisitions and strategic alliances with existing customers for its solutions such as electronic medical record (EMR) and computerized physician order entry (CPOE).

The global medical devices connectivity market is expected to reach a value of US$33.5 bn by 2019, exhibiting a phenomenal CAGR on account of stiff competition among companies operating in the domain.

You can purchase and download the full report
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1529

Hospitals Account for Lion’s Share of the Market as Fully Automated Systems Save Time and Prevent Costly Errors

The global market for medical device connectivity is segmented into wired hardware, software, and wireless hardware by component. Among them, the wired hardware section holds a lion’s share of the market and is predicted to retain its dominant position in the coming years. It is expected to achieve a market value of US$14.227 bn by 2019. The software segment, however, will register a growth rate faster than any other segment in the near future as most connectivity solution providers offer software solutions that support the existing infrastructure of the hospital.

Based on end users, the TMR report divides the market into three: home healthcare, hospitals, and others such as long-term care facilities, care homes, and skilled nursing homes. Hospitals hold a major chunk of the market as the integration of data from crucial healthcare equipment into EMR helps save time and prevents transcription errors. Government regulations mandating EMR is poised to boost the MDC market in hospitals, predicts the report.

Globally, North America is the dominant market for MDC. It was worth US$5.74 bn in 2015 and is expected to exhibit strong growth in the years to come on account of a growing geriatric population that is driving the demand for MDC. Europe follows North America in terms of market share, while Asia Pacific and the Rest of the World are still in a nascent stage.

Operational and Technical Glitches in Connecting Devices Thwarting End Users from Adopting MDC

A growing number of elderly people and others afflicted by chronic diseases such as asthma, heart disease, or diabetes, which require prolonged treatment, prefer home healthcare. This is slated to boost the market strongly, particularly in the U.S. This, alongside the fact that it saves nurses the time spent on recording data manually on each patient, is also leading to rising popularity for automated processes, thereby filliping the MDC market.

While the advantages of MDC are many, medical device manufacturers and hospitals are sometimes plagued by operational and technical glitches in connecting devices. “One of the challenges is related to the translation of data from various proprietary device formats into a format understandable by EMRs. Operational challenges include security protocols, the support of multiple interfaces in addition to serial connections, the support of standard wireless-networking security protocols, and the support of dual-band wireless communications,” explains the analyst of the TMR report.

Browse Research Report on Global Medical Device Connectivity (MDC) Market:
http://www.transparencymarketresearch.com/pressrelease/global-medical-device-connectivity-industry.htm

Intravenous Access Devices Market to be Driven by Large Patient Pool in Developing Economies

A new Transparency Market Research report states that the global intravenous access devices market stood at US$27.2 bn in 2012 and is predicted to reach US$46.5 bn by 2019. It is predicted to expand at a CAGR of 7.80% from 2013 to 2019. The title of the report is “Intravenous Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”

Get Sample Research Report on Intravenous Access Devices Market:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1723
 
As per the report, the increasing occurrence of targeted diseases such as viral infections and cancers and technological developments in products are amongst the chief factors stimulating the market for intravenous access devices. In addition, factors such as the rising global aging population and rising advancements in vaccines will further augment the growth of the market for intravenous access devices. Furthermore, the increasing disposable incomes of consumers in developing countries and the increasing patient pool have emerged as key opportunities in the market. On the other hand, factors such as the absence of regulatory approvals for intravenous insulin infusion pumps within the key markets such as the U.S. market may impede the growth of the overall market. In addition, the risks involved in the usage of needles may also have a negative impact on the growth of the market.

On the basis of product type, the market is segmented into intravenous catheters, intravenous needles, and intravenous infusion pumps. Amongst these, the segment of intravenous catheters is further segmented into midline peripheral catheters and central catheters. The segment of intravenous infusion pumps is further segmented into insulin fusion pumps, patient controlled analgesia (PCA) infusion pumps, parenteral feeding infusion pumps, and syringe infusion pumps. Amongst these, in 2012, on the basis of revenue, intravenous catheters held the largest share in the market and is predicted to expand at the greatest CAGR in the forecast horizon. This is due to their extensive utilization along with a number of other access devices such as needles and infusion pumps. In addition, the economical prices of intravenous catheters as compared to infusion pumps will further augment their demand.

In terms of geography, the report segments the market into North America, Europe, the Middle East and Africa (EMEA), Asia Pacific, and Rest of the World (RoW). Amongst these, North America held the largest share in the market on the basis of revenue in 2012 due to the growing aging population and the increasing prevalence of viral infections and cancers. On the other hand, Asia Pacific is predicted to exhibit the greatest CAGR of 9.40% between 2013 and 2019. This is due to the improved healthcare infrastructure and the rising healthcare expenditure in this region.

As stated in the report, the prominent players dominant in the market are Becton, Dickinson and Company, Hospira, Inc., CareFusion Corporation, B. Braun Melsungen AG, Smiths Medical, and Baxter International, among others.

Browse Research Report on Global Intravenous Access Devices Market:
http://www.transparencymarketresearch.com/intravenous-access-devices.html

Wheelchair Accessible Vehicle Converters Market - North America Industry Analysis in 2024

The North America wheelchair accessible vehicle (WAV) converters market is consolidated, with the top three players – BraunAbility, Vantage Mobility International, and Mobility Ventures LLC – accounting for over 65% in 2015. Transparency Market Research has observed that WAV manufacturers and vehicle converters are increasingly focusing on strengthening their distribution networks, developing a steady sales force, and conducting awareness programs in order to increase the adoption of WAVs over the forecast period.

Transportation companies are also looking to capitalize on the opportunities presented by this market through WAV taxi services. For instance, in July 2015, Uber Technologies, Inc. announced the launch of UberACCESS, which provides mobility vehicles for disabled customers. Wheelchair accessible vehicle taxi services are gaining traction in the U.S. and this is expected to give the WAV converters market a considerable boost in the coming years.

The value of the North America wheelchair accessible vehicle converters market was pegged at US$781.8 mn in 2015 and is expected to reach US$1.9 bn by 2024, registering a CAGR of 11.1% therein.

Download Complete Healthcare Analytical Brochure: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16094

By Entry Modality, Ramps Present Most Lucrative Opportunities for Players

On the basis of size of vehicle, full-sized vehicles are expected to account for a 73.1% share in the wheelchair accessible vehicle converters market by 2024. Small-sized vehicles, on the other hand, form the most attractive segment. This segment is projected to expand at a strong CAGR of 11.4% from 2016 to 2024.

By entry modality, ramps form the leading segment of the wheelchair accessible vehicle converters market in North America and this segment is anticipated to exhibit high growth through the forecast period.

From a geographical standpoint, the U.S. market is estimated to account for an 88.3% revenue share by 2024, emerging as the clear leader in the North America wheelchair accessible vehicle converters market. The U.S. is also projected to be the most lucrative segment by 2024.

Introduction of Preemptive Accommodations by WAV Manufacturers a Key Marketing Strategy

One of the key factors driving the North America market for wheelchair accessible vehicle converters is the significant prevalence of people with disabilities. A recent study published by the Centers for Disease Control and Prevention (CDC) states that one out of every five adults in the U.S. has a disability. This translates to roughly 53 million adults currently living with some form of disability. Disabled World, an independent news portal, reveals that an estimated 6.8 million community-resident Americans use mobility assistive devices, of which, at least 1.7 million individuals are wheelchair or scooter riders. “With the number of people living from disabilities on the rise, the demand for wheelchair accessible vehicle converters is bound to grow,” the TMR analyst states.

Looking to increase the adoption rate of wheelchair accessible vehicles and offer more benefits to customers, WAV manufacturers are focusing on integrating advanced technologies with their products. The introduction of preemptive accommodations is one such example, wherein WAV manufacturing companies are partnering with parking authorities in major cities to notify WAV users regarding the availability of parking spaces. Developments such as these are sure to boost the wheelchair accessible vehicle converters market in North America.

On the flip side, the high cost of wheelchair accessible vehicles and low awareness among potential customers are expected to significantly hamper the adoption rate of mobility vehicles, thereby hurting the wheelchair accessible vehicle converters market in North America.

Browse Research Report on U.S. Wheelchair Accessible Vehicle Converters Market:
http://www.transparencymarketresearch.com/north-america-wheelchair-accessible-vehicle-converters-market.html

Kaposi Sarcoma Market expanding at a 2.6% CAGR from 2016 to 2024

The global market for Kaposi sarcoma is projected to expand at a modest 2.2% CAGR from 2016 to 2024, with the opportunity in the market rising from US$118.5 mn in 2015 to be worth US$143.2 mn by the end of the forecast period. Hospitals formed the leading distribution channel in 2015, generating over US$40 mn revenue that year. The segment is also slated emerge as the fastest growing segment in the KS market, expanding at a 2.6% CAGR from 2016 to 2024.

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3354

The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of several major drugs.

Partnerships, acquisitions, and collaborations with other leading companies for the development of newer products with improved efficacy are part of the growth strategies adopted by a number of players in the Kaposi sarcoma market. For instance, F. Hoffmann-La Roche Ltd launched a new Global Access Program in September 2014 in partnership with the Joint United Nations Program on HIV/AIDS, the President’s Emergency Plan for AIDS Relief, the Clinton Health Access Initiative, and the Global Fund. The program was centered on HIV viral load testing.

High Incidence of HIV/AIDS, Organ Transplants Driving Growth of KS Market 

Increased organ transplant procedures are a leading factor driving the Kaposi sarcoma market since the incidence of the cancer is high among patients who have undergone an organ transplant. “Organ transplant patients are given immunosuppressive agents to prevent their body from rejecting the graft. This makes them highly susceptible to Kaposi sarcoma associated herpesvirus (KSHV) infection,” the author of the study explains. The long term use of these agents increases the rate of risk of these patients by more than 100 times compared to the general population.

The high incidence of HIV/AIDS associated Kaposi sarcoma is one of the major factors driving the adoption of HAART therapy, which subsequently fuels the overall KS market.

High Cost of Treatment a Major Drawback 

The cost of cancer drugs used for the treatment of Kaposi sarcoma has been on the rise in the past few years, making it difficult for patients to seek treatment. This is a major concern for both the patients and the payers. “The prices of patented drugs have increased by over five times in the past few years in the U.S. and continue to rise,” the TMR analyst comments. For instance, prices of major drugs used for the treatment of KS, such as liposomal doxorubicin, liposomal daunorubicin, or paclitaxel in combination with HAART, have been increasing significantly, making these unaffordable for middle and lower income groups.

Slow but Steady Growth in Store for Kaposi Sarcoma Market 

By type of treatment, HAART led the overall Kaposi sarcoma market in terms of revenue, with chemotherapy and immunotherapy poised to register the highest growth rate over the coming years. In terms of region, the global Kaposi sarcoma market was led by North America in 2015 and the MEA region will record the fastest growth by 2024.

Browse Research Report on Global Kaposi Sarcoma Market:
http://www.transparencymarketresearch.com/kaposis-sarcoma-market.html

Lifestyle Changes Resulting in High Infertility Rates to Propel Global Human Reproductive Technologies Market

A recent report on the global human reproductive technologies market has been published by Transparency Market Research. The report, titled “Human Reproductive Technologies Market - Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 - 2019,” projects this market to expand at a CAGR of 2.20% during the period from 2013 to 2019. The market is estimated to stand at a valuation of US$27.1 bn by 2019.According to the World Health Organization, in 2010, about 1.9% of the female population worldwide in the age group of 20-44 years was unable to conceive the first child. The growing prevalence of infertility has been attributed to a number of environmental and socio-economic factors. The various human reproductive technologies have witnessed increasing popularity in the past couple of years for the treatment of infertility among both men and women.

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1876
 
With the rise in female employment, there has been a growing trend of a delay in conception. Factors such as pollution, smoking, stress, and obesity have led to an increase in infertile population. The growing prevalence of unwanted pregnancies, initiatives taken by governments and NGOs to promote contraceptive products, and the implementation of favorable policies such as the Affordable Care Act has propelled the growth of the global human reproductive technologies market.

However, limited insurance coverage and the side effects of contraceptive drugs and devices might hamper the growth of the market during the forecast period. The global human reproductive technologies market has a significant opportunity to grow with the rise in medical tourism, government support for the treatment of infertility, and the presence of a strong pipeline of contraceptive drugs.

The market for contraceptives stood at a valuation of US$16 bn in 2012. During the forecast period, the market is estimated to expand at a CAGR of 5.5%. In 2012, the oral contraceptives segment witnessed the highest demand due to the availability of contraceptives as an over-the-counter drug.

The key regions in the global human reproductive technologies market are Europe, Asia Pacific, North America, and Rest of the World. In 2012, North America emerged as the leading region in the market, followed by Europe. North America is predicted to dominate the market throughout the forecast period. However, the market is projected to register the fastest growth in Asia Pacific due to the increasing awareness about contraceptives, high population density, and rise in disposable income.

Some of the major players in the global human reproductive technologies market are Bayer AG, Abbott Laboratories, Actavis Inc., Boston Scientific Corporation, Church & Dwight Co. Inc., Merck KGaA, Warner Chilcott plc, Reckitt Benckiser Group plc, Merck Serono, Pfizer Inc., Johnson & Johnson, Cook Medical Inc., and Teva Pharmaceutical Industries Ltd. The report discusses some of the key attributes of the market players including their business strategies, product portfolio, and recent developments. Through a SWOT analysis, the report identifies the future growth opportunities for the market vendors.

Browse Research Report on Global Human Reproductive Technologies Market:
http://www.transparencymarketresearch.com/human-reproductive-technologies-market.html

North America Nitinol Medical Devices Market Revenue for Final Medical Components

Transparency Market Research as announced the publication of a new research report that examines the global nitinol medical devices market in great depth. The research report, titled “Nitinol Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” offers an evaluation of the strengths, weaknesses, opportunities, and threats in the market with the help of a SWOT analysis and assesses the threat of new entrants, threat of substitute products or services, bargaining power of customers (buyers), bargaining power of suppliers, and intensity of competitive rivalry with Porter’s five forces analysis.

Get Sample Research Report with ToC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1685
 
According to the research report, the global nitinol medical devices market for semi-finished goods was worth US$1.5 bn in 2012 and is expected to register a remarkable compounded annual growth rate of 7.30% to reach a valuation of US$2.5 bn by 2019. On the other hand, the global nitinol medical devices market for final medical components was worth US$8.2 bn in 2012 and is expected to register a CAGR of 11.10% to reach US$17.3 bn by the end of 2019.

In the past few years, the number of vascular disorders, such as carotid artery disease, venous disease, renal artery disease, abdominal aortic aneurysm, peripheral artery disease, and stroke have witnessed an unfortunate rise. The underlying current for this trend is the growing number of obese people and the subsequent demand for invasive surgery techniques, which has led to the growth of the global nitinol medical devices market. As this situation continues, the growth in the demand for nitinol medical equipment will also continue. Additionally, acceptance of nitinol medical equipment and a rise in the manufacture of various medical devices that use nitinol is also expected to propel the growth of this market in the near future.

The global nitinol medical devices market is segmented on the basis of type, components, and geography. The types of nitinol medical devices in the market are: semi-finished raw material and final medical components. The semi-finished raw material segment is further sub-segmented into tubes, wiring, and others such as ribbons and sheets. The final medical components segment is further divided into stents, guidewires, and others. Geographically, this market is segmented into North America, Europe, Asia Pacific, and Rest of the World.

In terms of regions, North America dominated the nitinol medical devices market in 2012. However, analysts predict that the Asia Pacific market for nitinol medical devices will grow at a rapid pace in the next three years. Furthermore, amongst the types of devices, the wiring sub-segment is expected have a CAGR of 8.2% from 2013 to 2019, while the stents sub-segment is estimated to leap forward at a pace of 13.20% CAGR in the same time frame.

Some of the important players profiled in the global nitinol medical devices market are Nitinol Devices & Components, Inc., Custom Wire Technologies, Inc., Boston Scientific Corporation, Abbott Laboratories, Inc., Cook Medical, Inc., and C.R. Bard, Inc. The research report also explains the competitive landscape in complete detail and shares important statistics pertaining to the financial overview, research and development activities, investment outlook, strategic mergers and acquisitions, and business and marketing strategies for the near future.

Browse Research Report on Global Nitinol Medical Devices Market:
http://www.transparencymarketresearch.com/nitinol-medical-devices.html

Cell and Tissue Analysis Products Market - Global Industry Analysis and Forecast 2016 - 2024

Cell and Tissue Analysis Products Market: Overview 

Great strides made in the cell and tissue analysis products market have revolutionized many aspects of modern healthcare and treatments, noteworthy among which are diagnosis of different types of cancer, and autoimmune diseases. Cell and tissue analysis products find takers in industries, namely pharmaceutical, biotechnology, and research. They have a wide variety of uses stem cell research, drug discovery and development, cell biology, and other research practices. 

Get Sample Research Report with ToC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1767

The report provides helpful insights into the cell and tissue analysis products market after thorough research. From a basic definition of cell and tissues and what cell and tissue analysis entails to the more sophisticated SWOT analysis, bringing to the fore strengths, weaknesses, opportunities, and threats influencing the segments of the global market – the report covers everything. It also provides distinctive graphics and segments the market based on geography. Additionally, it also uses a Porter’s five forces analysis that helps in determining the threat of new entrants, bargaining power of buyers and suppliers, and the intensity of the competitive rivalry. 

Further, the report delves into each product segment based on underlying technologies, its current market, and growth prospects. It endeavors to keep you abreast of the changing competitive landscape by furnishing details of historical developments and current market scenario and size. The researchers combine the two to predict growth prospects of the market – a seven-year forecast of market growth pattern 

Cell and Tissue Analysis Products Market: Trends and Opportunities

Increasing medical awareness among people, government support for healthcare and growing number of diagnostic centers are the main market growth drivers for cell and tissue analysis products. Besides, increasing spend on research and development, new technologies, new product launches and rise in lifestyle associated diseases, and growing incidence of cancer, has driven demand in the market for cell and tissue analysis products. Many modern industries trying to deploy cell and tissue analysis products in their production and process leads, has also provided a fillip to the market. Increasing competition and patent expiries, however, are proving to be a drag on companies’ performances. Given the high capital requirements to start a business in the domain and advanced stage of technology, newcomers find it a difficult market to break into. 

Apart of growth drivers and restraints, the report also covers the key product segments based on their underpinning technologies. They are: bio specimen technologies that include DNA microarray and tissue microarray; cell and tissue separation products which include enzymatic dissociators, magnetic separation, laser micro dissection, and flow cytometry; and cell and tissue characterization products which comprise research antibodies, high content screening, and cell-based assays. 

Cell and Tissue Analysis Products Market: Region-wise Outlook

Geographically, the cell and tissue analysis products market has been segmented into North America, Europe, Asia Pacific, and the rest of the world. Of them, North America is the prime consumer of cell and tissue analysis products. Countries in Asia Pacific such as Japan, India, and China, are also driving up demand in the market on account proliferation of research activities in various areas such as cancer and HIV and also on account of increasing diagnostic centers to cater to their people’s rising medical awareness. The market for cell and tissue analysis products, however, is highly fragmented with the presence of many large, medium-sized and small manufacturers that supply diagnostic products. Competition is stiff, with vendors constantly trying to form partnerships to guard their market share. 

Key Players Mentioned in the Report are:

The key players operating in the global cell and tissue analysis products market are Beckman Coulter, Millipore, Thermo-fisher Scientific, Abcam, Sigma-Aldrich, and TGA Sciences. 

Browse Research Report on Cell and Tissue Analysis Products Market:
http://www.transparencymarketresearch.com/cell-tissue-analysis-products.html

Malignant Neoplasm Therapeutics Market Size, Share and Industry Trends 2024

Malignant neoplasm is believed to be one of the extended conditions of neoplasm. It is a form of cancer that develops an abnormal growth of tissues usually leading to the formation of a tumor. The primary cause of this disease is understood as damaging of DNA under certain circumstances that further escalates to a stage of cancer. The very beginning of malignant neoplasm is the occurrence of abnormal patterns of growth in the tissue known as dysplasia or metaplasia.

Get Sample Research Report with TOC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14792

Higher Prevalence of Malignant Neoplasm in Geriatric Population Driving the Market Growth

The global cancer incidences have increased to a considerable number over the past few decades owing to a rise in the geriatric population, increasing life expectancy and changing lifestyle. In addition, factors such as advanced cancer diagnostics and early initiation of the treatment are fuelling the global malignant neoplasm therapeutics market. Development of targeted therapies are revolutionizing the conventional concepts of cancer treatment and are likely to get higher preference in the coming years. Moreover, a higher success ratio of these latest cancer drugs compared to traditional anti-carcinogenic treatment is expected to further drive the market growth in the near future. These latest drugs are capable of countering more than one type of cancer. For example ‘imatinib’, which was first developed for treating a single type of cancer was later found effective on multiple cancer types.

Novelty in cancer treatment has significantly influenced the present treatment models. However, a complete cure for the disease is still not ascertained. Further, many of the advanced treatment models are often expensive and only available in developed regions of the world. In some case, delay in integration of the novel drugs into current treatment methods limit the options for the patient.  Other factors such as price risk and credibility of the drugs are few of the other concerns for the market.

Over the years, the subject of oncology has received paramount attention from biomedical researchers, health care experts and pharmaceutical manufacturers. Owing to a severe need for effective treatment of cancer, heavy investments are being made in further research and development of the particular subject. Many of the pharmaceutical companies such as Novartis International AG and Pfizer Inc. are introducing a range of anti-carcinogenic drugs under their brand names promising to be more efficient. The global malignant neoplasm treatment market has become increasingly competitive in the recent years with more player joining in. Currently, most drug manufacturers offer two primary cancer therapeutic programs, namely cytostatic hormonal treatments and antineoplastics. 

Malignant Neoplasm Therapeutics Market: Regional Segmentation

On the basis of region, the global malignant neoplasm therapeutics market has been segmented into six key regions namely North America, Western Europe, Eastern Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa. North America is considered as one of the largest market of malignant neoplasm therapeutics owing to a strong presence of drug manufacturers in the region and availability of advanced healthcare facilities. In terms of value, the U.S accounts for a healthy portion of the global malignant neoplasm therapeutics market attributed to the growing demand for cancer treatment in the country. In addition, Europe is one of the other regions where the market is growing at a considerable rate and is expected to continue a similar in trend in the coming years. 

Key Players

Few of the key players identified in the global malignant neoplasm therapeutics market include F. Hoffmann-La Roche AG, Novartis International AG, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Takeda Pharmaceutical Company Ltd, Pfizer Inc. Bayer AG, Amgen, AbbVie Inc and Celgene Corporation.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Browse Research Report on Global Malignant Neoplasm Therapeutics Market:
http://www.transparencymarketresearch.com/malignant-neoplasm-therapeutics-market.html

Medical Measurement Solutions Market Global Industry Trends and Forecast 2024

Measurement Solutions for the Medical Device Industry: Overview

Revolution in the medical device industry has fully-fledged along with the demand for premium healthcare. The medical device sector covers broad range of applications with a wide variety of advanced products including dental equipment, diagnostic devices, cardiovascular devices, surgical equipment, medical equipment, ophthalmic devices, orthopedic and respiratory devices. Measurement solutions includes sensor applications & solutions, testing equipment and services, software testing solutions, instruments, equipment automation solutions etc. for the medical device industry. Predominantly prominent technological advancement in recent years includes new developments in neurology, cardiology and Health IT (e.g. Information sharing, wireless devices, systems for monitoring the cardiac activity etc.) E.g. Experts have also recycled the nanosensors technology for the rapid detection of cancers. Partnerships and acquisitions have led to new technology in biomarkers, robotic assistance, implantable electronic devices, liquid bandages/wound dressings and ingestible diagnostic devices. Measurement solutions also continues to benefit from a new procedures of nanotechnology and micro-electro-mechanical systems (MEMS).

Get Sample Research Report with TOC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15302

Drivers and Restraints

Global demand for overall measurement solutions for medical devices is mainly driven by rise in healthcare expenditures and greater attention to health care by emerging markets, rise in development of hospitals and specialty clinics, and establishment of public health insurance. In addition, overall demand is growing worldwide due to aging population in major markets and increasing global income levels in developing countries. The USFDA is functioning towards increasing the number of electronic applications for approval and has published suggested rules that would require electronic reporting of post-market medical device adverse events. In recent years medical device industry is driven by innovation and the ongoing expedition for better ways of diagnosing medical hitches, future growth scenarios for this sector remain positive. Further, global management of standards and regulatory requirements may help simplify overall market growth. Measurement solutions for the medical devices are now creating an intensive market to keep patients healthier and minimize costs by neglecting unnecessary hospitalizations. This adoption is really a value based shift payment for medical device providers. 

Global Ventilators Market: Segmentation

The Global Ventilators Market market can be segmented as follows:

Global ventilator accessories market by Device Type

• Drug Delivery Devices
• Surgical Tools
• Orthopedics
• Robotic Surgery
• Therapeutic Devices
• Others (Sensors, Digital Software etc.) 

Global Ventilators Market, by End User

• Hospitals
• Ambulatory Surgery Centres
• Clinics
• Emergency Medical Services
• Long term care centres
• Home Care Settings
• Regional Outlook

Geographically, the measurement solutions for the medical device industry is segmented into five regions, namely North America, Latin America, Europe, Asia Pacific & Middle East and Africa. North America medical device sector is expected to persist highly competitive globally. Measurement solutions for the medical device industry is an accepted, necessary component of the U.S. healthcare system. Rise in number of multinational medical device manufacturing firms are looking for regulatory approval for their products in more countries worldwide. Medical device solution providers are now more focused in expanding the product portfolio in other developing regions to drive future growth. For e.g., more demand for medical devices in Asia pacific is increasing at a higher rate compared to developed countries. In Asia pacific regions electronics and medical device industries are starting to make acquisitions, now improving the efficiency of the healthcare delivery system as well as workforce in other sectors too.

Measurement solutions for the medical devices needs a complete understanding of equipment operation, device automation, application and testing. Manufacturers are launching innovative products such as sensors, testing equipment, scanners, measurement systems or any other measurement solutions with a high degree of expertise. Measurement solution for medical devices demands more safety and quality measurement protocols. Medical device development faces specific challenges that also affect most companies these days mainly due to increased competition in sales and service in the international market, also facing issues in the durability and development of advanced automated solutions.

Browse Research Report on Global Measurement Solutions for the Medical Device Market:
http://www.transparencymarketresearch.com/measurement-solutions-medical-device-market.html

Advance Basal Cell Carcinoma Market Global Analysis and Trends in 2024

Advance basal cell carcinoma are abnormal, uncontrolled growths or lesions which appear on the skin, they arise from basal cells of the skin which are found on the inner most layer epidermis. They look like open sores, pink growths, red patches or scars which are caused due to cumulative and intense exposure to the sun. Basal cell carcinoma generally does not spread beyond the original site of the tumor, they mostly affect the head, face scalp, hand and the neck areas but spread to other parts and become malignant if not diagnosed.

Get Sample Research Report with TOC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15185

Basal cell carcinoma is the most common form of skin cancer which accounts for nearly 80% of all cases, if not treated may get into the advance stage. Basal cell carcinoma which infiltrates below the skin or vital organ is difficult to treat surgically. It is commonly found in elderly and fair skinned individuals. Treatment of advance basal cell carcinoma is carried out with surgical, destructive and topical therapeutic treatments. Although if not treated properly or neglected it may become aggressive or recurrent basal cell carcinoma may progress to an advanced state. The characteristics of a tumor becoming advance basal cell carcinoma may differ. The major challenges in treating advance basal cell carcinoma include its size, location, invasiveness and extent. It comprises of non-melanoma skin cells as compared to other malignancies. Individuals suffering from advance basal cell carcinoma fall under two categories, one who have advance basal cell carcinoma due to delay in accessing medical treatment and with whom basal cell carcinoma reoccur after treatment.

The treatment for advance basal cell carcinoma is quite complicated as both patients and tumor characteristics have to be taken into consideration before starting the treatment. Generally, more than one therapeutic methodology has to be taken into account for the treatment. The mortality rate for basal cell carcinoma is low as compared to other forms of malignant tumors as these rarely become malignant, these tumors are generally curable but sometimes due to reoccurrence it is hard to completely get rid.

There are many different ways to prevent basal cell carcinoma, such as by avoiding skin exposure to direct sunlight, this can be avoided by using high factor sunscreen to exposed skin if outdoors. Cases which are associated with high cost and recovery time the use of radiation therapy or hedgehog inhibitor therapy may be taken into consideration. In some cases where surgery may not be sufficient alternative medication is used which could be topical, oral or hedgehog inhibitors may be taken into consideration. In recent times newer and more effective therapeutics have been developed which include inhibitors which block the Hedgehog pathway which stops the reoccurrence of advance basal cell carcinoma. These new therapeutics would help in extending the lifespan of people who have metastatic advance basal cell carcinoma. Advance basal cell carcinoma are sometime difficult to treat and can become life threatening this is mainly due to reoccurrence rate and progressiveness of the disease.Therefore it requires constant monitoring. The American Cancer Society strongly recommends dermatologic checkup in every three years for individuals between 20-40 years of age and every year for individual above 40 years of age.

The global market for advance basal cell carcinoma is segmented into five key regions viz.  North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The region of North America leads the market for advanced basal cell carcinoma therapeutics and is closely followed by European region. It is estimated that in coming years more people will get affected by advance basal cell carcinoma in the U.S and the U.K. In recent times the Asia-Pacific region has observed a substantial growth in advance basal cell carcinoma therapeutic market as number of people are getting affected by advance basal cell carcinoma, thus increasing the demand for therapeutics in the region.

The major factors driving the growth of the market for advance basal cell carcinoma are increasing aging population, environmental changes, increased use of immunosuppressant, increased exposure to sunlight, increased demand for new therapeutics and better reimbursement policies. The restraining factor for advance basal cell carcinoma therapeutics market is delay in accessing medical condition, lack of awareness amongst individual and cost of certain therapeutics. As technological advancements are made some therapeutic drugs are being discovered which are in clinical trials and different phases of development would help the therapeutic market for advance basal cell carcinoma to grow. Key players involved in advance basal cell carcinoma market are F. Hoffmann-La Roche Ltd., Novartis, Genentech Inc., Merck & Co. Inc., Bristol-Myers Squibb Company, Amgen Inc., Cannabis Science, INC., Curis Inc., Galderma S.A., Prime Therapeutics LLC, and Graceway Pharmaceuticals.

Browse Research Report on Global Advance Basal Cell Carcinoma Market:
http://www.transparencymarketresearch.com/advance-basal-cell-carcinoma-market.html

Genetic Analysis Services Market The Largest Market in North America

There is a huge potential for uptake of genetic analysis services with the increasing understanding of genes among individuals. Over the past few years, the technology involved in genetic analysis has evolved and advanced to an extent where amateur, aspiring, or experienced scientists can easily acquire the materials required to conduct a genetic analysis of their own. A new research report by Transparency Market Research (TMR) titled “Genetic Analysis Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020,” offers insights into historical data and expected future trends of the market. It also discusses the factors influencing the growth of the market throughout the forecast period.

Get Sample Research Report with TOC: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2555

The rising awareness regarding genetic studies is primarily driving the global genetic analysis services market. There is an increasing adoption of these services in judiciary sciences to confirm a person/suspect’s identity and in the healthcare sector to determine the prevalence of diseases and errors in metabolic functioning of the body. This factor is likely to augment the growth of the market. Other factors such as increasing prevalence of life-threatening diseases such as Alzheimer and cancer and the abundant availability of primers, chemicals, and equipment required for genetic tests are fuelling the growth of the market. 

On the flip side, the absence of conducive regulations prevents private institutes from evaluating patients or consumers health in the foreseeable future on the mere reports of these services. Furthermore, the high cost of instruments required to perform genetic analysis is impeding the adoption of genetic analysis services. Other factors adversely affecting the growth of the market are the economic slowdown in certain regions coupled with the lack of favorable reimbursement policies.

Some of the applications of genetic analysis services are drug discovery, biomarkers, and diagnostics. Geographically, North America is estimated to be the leading market throughout the forecast period. The presence of well-developed healthcare infrastructure, increasing awareness regarding genetic studies and rising per capita expenditure on healthcare are propelling the growth of this region. Asia Pacific is estimated to rise at an impressive growth rate during the same period owing to rising healthcare expenditure levels, increasing research and development activities pertaining to genomics, and improving healthcare facilities.

In the recent times, there has been an upswing in the number of new players offering these services at various price ranges depending upon their degree of accuracy, type of service, and details. Some of the key companies in the global genetic analysis services market are 23andMe, Affymetric Inc., Agilent Technologies, Bio-Rad Laboratories, GE Healthcare, Illumina, Inc., Life Technologies, Roche Diagnostics Corporation, and Qiagen N.V. 

Browse Research Report on Genetic Analysis Services Market:
http://www.transparencymarketresearch.com/genetic-analysis-services-market.html

Ophthalmic Devices Market Trends, Size and Industry Analysis in 2018

The global ophthalmic devices market is experiencing significant growth because of increasing incidences and prevalence of eye related disorders like presbyopia, diabetic retinopathy, and macular degeneration. With the introduction of sophisticated technology in ophthalmic devices, people are opting for ophthalmic surgeries to correct eye related disorders. As a result, the global ophthalmic devices market is expected to register a compounded annual growth rate of approximately 4% during 2011 to 2017. 

Request a Free PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=283

Increasing eye diseases and the growing elderly population are some of the factors driving the market of ophthalmic devices. Minimally invasive surgical procedures and advances in laser technology are boosting the growth of ophthalmic surgical devices. Developing countries like India and China are expected to show potential for market growth due to the presence of a large patient base in the rural areas. Technological improvements along with availability and accessibility of treatment procedures for various vision problems are some of the factors leading to the growth of ophthalmic devices market. 

This research report analyzes the global ophthalmic devices market, discussing the detailed overview and market figures. This report also studies the industry growth rate¸ capacity, and industry structure. It includes the study of current developments in ophthalmic devices market, Porter’s five force analysis, and detailed profiles of the top industry players. The research report on ophthalmic devices market provides a detailed review of macro and micro factors significant for the existing market players and new entrants along with detailed value chain analysis. 

Ophthalmic Devices Market Segmentation 

Ophthalmic devices market is segmented as follows: 

• Cataract Surgery Devices
• Refractive Surgery Devices
• Vision Care
• Ophthalmic Diagnostic Devices 
• Vitreo Retinal Surgery Devices 
• Glaucoma Surgery Devices  

The major geographies studied under this research are North America, Europe, Asia-Pacific, and the Rest of the World.

The key players dominating this market are Essilor International, CIBA Vision Corporation, Johnson & Johnson Vision Care Inc., Solotica Lentes de Contato, Alcon Inc., Bausch & Lomb Incorporated, Cooper Vision Inc., Carl Zeiss AG, Abbott Medical Optics Inc., Hoya Corporation, etc. 

Browse Research Report on Global Ophthalmic Devices Market:
http://www.transparencymarketresearch.com/ophthalmic-devices-market.html

Healthcare M2M Market: Growing Demand from Asia Pacific to Expand Market at 22.5% CAGR during 2015-2023

Innovation and simplicity in healthcare data management will be a key factor for the global healthcare M2M market in the coming years. Transparency Market Research states that companies will develop cloud-based ecosystems to keep up with the inflow of data along with ensuring its flawless management to keep in line with this trend. For instance, GE Healthcare launched its “GE Health Cloud” in November 2015, which promises to lend flexibility and ease in managing large volumes of healthcare data. 

Download Free exclusive Sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8590

The key players leading the global healthcare M2M market are Vodafone Plc, AT&T, Inc., and Telefonica S.A. with their own M2M platforms. “Companies will also try to reduce the gap between patients and physicians to increase their brand presence,” said the author of this research report. To maintain the brand value companies will enter strategic alliances that will help them update their platforms in the near future. How these companies incorporate technologies to make healthcare extremely accessible and accurate to the everyday user will remain the focal point of this market in the coming years.

Need to Add Accuracy to Healthcare Pushes Adoption of Healthcare M2M Platforms

Statistics by World Health Organization (WHO) indicate that as of 2014 there was a deficit of 7.2 million healthcare professionals across the globe to cater to the medical needs of the population. Researchers predict that this gap will widen by 2.5% with each passing year. The need to bridge this gap between demand and supply is expected to boost the adoption of M2M solutions in the overall healthcare industry.

The increasing administrative work that is escalating the operational costs of healthcare facilities is also coaxing managements to utilize M2M-based solutions. Not only are these solutions cost-effective but also bring in efficiency by eliminating the cumbersome paperwork. These solutions also reduce the risk of medical errors and are thus known to deliver accurate results.

Alternate Technologies Interfere with Successful Deployment Healthcare M2M

The large-scale deployment of M2M solutions in the healthcare industry is being hampered by the presence of alternate technologies such as IMAX, Satellite, 2G/3G, and Bluetooth. The wireless standards of these technologies differ, making it exceptionally difficult for adopting M2M across the sprawling healthcare sector. As the wireless technology still remains in the nascent stage in the developing countries such as Africa, the global usage of M2M solutions is expected to take time.

Smart healthcare has a huge potential to grow in the near future due to the proliferation of Internet of Things (IoT) in the majority of sectors. Developing regions that are focusing on patient-centric health that ensure efficient treatment procedures will also open up new growth opportunities for the global healthcare M2M market in the near future.

According to Transparency Market Research, the opportunity in the global healthcare M2M market was worth US$1,562.4 mn in 2014 and is expected to reach US$10,052.3 mn by the end of 2023. This market will rise at a CAGR of 22.5% between 2015 and 2023. The key application segment in this market is anticipated to be sports and fitness segment as it expands at a CAGR of 26.5% between 2015 and 2023. Geographically, though North America will be a key regional contributor, Asia Pacific is estimated to growing at the fastest CAGR of 26.9% during the forecast period.

Browse Research Report on Global Healthcare M2M Market:
http://www.transparencymarketresearch.com/pressrelease/healthcare-m2m-market.htm

Cell Culture Media Market to expand at a CAGR of 8.8% between 2014 and 2022

The top three players leading the global cell culture market are Thermo Fisher Scientific, BD Biosciences, and EMD Millipore and their cumulative share in the market amounted to 52% in 2014, states Transparency Market Research in its new research report. The groundbreaking work towards developing vital biomolecules and therapeutics using cell culture techniques has put these companies on the much-deserving pedestal. In the coming years, companies will focus on manufacturing and research activities that will be driven by growing investments in a specific type of biomanufacturing process. 

View exclusive Global strategic Business report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6598

“High degree of product differentiation will play a key role in determining the winning strategies of the companies in the global market,” says the lead author of this research report. Currently, companies are engaged in the development of 3D cell culture technology that delivers even more accurate results than 2D cell culture. New product launches, collaborations, and the expansion of product portfolios will be the key focus areas for players to expand their businesses in the near future.

Customization of Treatments Drives Global Market

The blurring lines between pharmaceutical and biotechnology companies have given birth to biotech companies that focus on stem cell research to design specialized treatments by personalizing medicine. The angle of specificity in treating ailments that are no longer responsive to conventional treatments has been the biggest driving factor for the global cell culture market. Additionally, the market has its hopes pinned on the growing trend of contract manufacturing, which is proving to be economically beneficial to several companies. 

The lack of competition from generic drugs, known as biosimilars, is also fostering the growth of the global market as it is nearly impossible for generic drug manufacturers to recreate unique processing of living organisms in controlled environmental conditions. The growing demand for artificial organs that are biologically engineered and used in replacement surgeries to restore the impaired parts is also spurring the growth of cell culture market.

Difficulty in Adhering to Parameters Hampers Market

The precision-driven cell culture processes are a major hindrance to the global cell culture market. Getting all the parameters such as temperature, nutrients, humidity, and aeration is exceptionally tough. Thus, the difficulty in adhering to these clauses is hampering the expansion potential of this market. Additionally, the development of alternative technologies instead of in vitro cell and tissue culture for biomanufacturing processes is likely to restrain the market size in the near future.

North America to Lead the Market during Forecast Period

According to the research report, the opportunity in the global cell culture market was worth US$6 bn in 2013 and is expected to reach a valuation of US$11.3 bn in 2022, expanding at a CAGR of 7.1% between 2014 and 2022. The cell culture media segment is anticipated to be the fastest-growing segment of the global market at a CAGR of 8.8% between 2014 and 2022. Regionally, North America led the overall market and is expected to contribute a revenue worth US$3.7 bn by 2022. Analysts predict that Asia Pacific is will be the emerging regional segment during the forecast period.

Browse Research Report on Global Cell Culture Media, Sera, and Reagents Market:
http://www.transparencymarketresearch.com/cell-culture-media-sera-reagents-market.html